RABEPRAZOLE 20 MG (EC) + DOMPERIDONE 10 MG (IR) + DOMPERIDONE 20 MG (SR) CAPSULE NEW TECHNOLOGY

Rabeprazole 20 MG (EC) + Domperidone 10 MG (IR) + Domperidone 20 MG (SR) Capsule New Technology is an innovative pharmaceutical formulation that combines the powerful acid-suppressing properties of rabeprazole with dual-release domperidone for comprehensive gastrointestinal relief. This advanced triple-component medication features enteric-coated rabeprazole that provides long-lasting protection from stomach acid, while the immediate-release and sustained-release domperidone work together to control nausea, vomiting, and enhance gastric motility throughout the day.

This cutting-edge formulation is specifically designed for patients suffering from conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and functional dyspepsia accompanied by upper gastrointestinal discomfort. The new technology ensures optimal drug release patterns, delivering immediate symptom relief followed by sustained therapeutic effects for up to 24 hours. By addressing both excess acid production and impaired gastric emptying simultaneously, this combination therapy offers superior management of complex digestive disorders. Ideal for individuals seeking advanced treatment for chronic acid-related conditions with associated motility issues, providing convenience and improved quality of life.